Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-24 @ 4:44 PM
NCT ID:
NCT03859466
Eligibility Criteria:
Inclusion criteria
* Male or female patients between 21 and 90 years of age undergoing primary coronary artery bypass grafting
* Presentation with reduced left ventricular function, defined as LVEF ≤ 40% measured by cardiac MRI
* Presentation with regional left ventricular wall motion abnormalities
* Written informed consent from the patient for participation in the study
Exclusion criteria
* Significant concomitant aortic valve disease requiring surgical treatment (other than significant aortic valve disease not detected in preoperative cardiac ultrasound but detected during surgery)
* Serious radiographic contrast allergy
* Patient in cardiogenic shock or presenting with acute myocardial infarction (STEMI or NSTEMI)
* Patient with a contraindication for cardiac MRI
* History of significant ventricular arrhythmia, other than MI-associated arrhythmia
* Comorbidity reducing life expectancy to less than one year
* Presence of a ventricular thrombus
* Presence of a cardiac tumour
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
90 Years
Study:
NCT03859466
Study Brief:
Protocol Section:
NCT03859466